PR Title: |
Case studies on drug development and novel targets from Glenmark Pharmaceuticals and Novartis at COPD 2016 |
PR Summary: |
SMi Group reports: Glenmark Pharmaceuticals and Novartis Pharma to join the speaker line up at this years' COPD conference in London on 19-20th October. |